- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00658853
Effective High Aerobic Intensity Endurance Training Regimes in Chronic Obstructive Pulmonary Disease (COPD) Patients
July 15, 2016 updated by: Norwegian University of Science and Technology
Effective High Aerobic Intensity Interval Training to Improve Maximal Oxygen Uptake in COPD Patients
4 times 4 minutes interval training with and without hyperoxia is more effective than low intensity endurance training.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Trondheim, Norway, NO-7489
- Norwegian University of Science and Technology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- COPD
Exclusion Criteria:
- Heart disease
- Walking or cycling inabilities
- Other diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 1
High aerobic intensity treadmill walking.
4 by 4 minutes interval training on a 5% graded treadmill at a heart rate corresponding to 85-95% of maximal heart rate.
3 times per week for 10 weeks.
|
3 times per week for 10 weeks
|
|
Active Comparator: 2
4 times 4 minutes interval training in hyperoxia - 100% oxygen
|
3 times per week for 10 weeks
|
|
Active Comparator: 3
One leg at a time training 4 times 4 minutes interval training using cycling ergometer
|
3 times per week for 10 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
VO2peak
Time Frame: 10 weeks
|
10 weeks
|
|
Ventilation
Time Frame: 10 weeks
|
10 weeks
|
|
FEV1
Time Frame: 10 weeks
|
10 weeks
|
|
Walking performance
Time Frame: 10 weeks
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Quality of life
Time Frame: 3 months
|
3 months
|
|
SPSS
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jan Helgerud, PhD, Norwegian University of Science and Technology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2004
Primary Completion (Actual)
February 1, 2006
Study Completion (Actual)
February 1, 2006
Study Registration Dates
First Submitted
April 10, 2008
First Submitted That Met QC Criteria
April 14, 2008
First Posted (Estimate)
April 15, 2008
Study Record Updates
Last Update Posted (Estimate)
July 18, 2016
Last Update Submitted That Met QC Criteria
July 15, 2016
Last Verified
July 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 149-03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.